Related Experiment Videos
[Amiodarone-induced pulmonary fibrosis]
C Lengyel1, I Boros, T Várkonyi
1Szent-Györgyi Albert Orvostudományi Egyetem, Szeged.
Orvosi Hetilap
|August 11, 1996
Summary
Long-term amiodarone therapy can cause severe lung fibrosis. Early detection of amiodarone pulmonary toxicity using high-resolution computed tomography (HRCT) is crucial for timely intervention.
Area of Science:
- Cardiology
- Pulmonology
- Pharmacology
Background:
- Amiodarone is a potent antiarrhythmic drug with known toxicities.
- Pulmonary toxicity, including fibrosis, is a significant concern with long-term amiodarone use.
Observation:
- A case of a patient receiving high-dose amiodarone unnecessarily for 4 years is presented.
- The patient developed drug-induced dermatopathy, hypothyroidism, and lung fibrosis.
Findings:
- Amiodarone-induced pulmonary toxicity may present with cough, dyspnea, and fever.
- High-resolution computed tomography (HRCT) can detect early pulmonary involvement before radiographic changes.
Implications:
- Prompt recognition of amiodarone pulmonary toxicity is vital.
- HRCT is a valuable tool for early diagnosis and management of amiodarone-induced lung disease.
- Glucocorticoid therapy may be indicated for persistent pulmonary complications.